SOPH (SOPHiA GENETICS SA Ordinary Shares) Stock Analysis - Hedge Fund Holdings
SOPHiA GENETICS SA Ordinary Shares (SOPH) is a publicly traded Healthcare sector company. As of May 20, 2026, SOPH trades at $4.79 with a market cap of $336.70M and a P/E ratio of 0.00. SOPH moved +3.42% today. Year to date, SOPH is +5.87%; over the trailing twelve months it is +69.10%. Its 52-week range spans $2.58 to $5.70. Analyst consensus is strong buy with an average price target of $7.50. Rallies surfaces SOPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SOPH stock?
Hedge funds tracked by Rallies that own SOPH include Akre Capital and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SOPHiA GENETICS SA Ordinary Shares.
SOPH Key Metrics
Key financial metrics for SOPH
Metric
Value
Price
$4.79
Market Cap
$336.70M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$5.70
52-Week Low
$2.58
Volume
56.05K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Top Hedge Funds Holding SOPH
Akre Capital holds 3.72M shares of SOPH, changed +0.00% as of Mar 31, 2026.
Polen Capital holds 21.74K shares of SOPH, changed +0.00% as of Dec 31, 2025.
Hedge funds tracked by Rallies that own SOPH include Akre Capital and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SOPHiA GENETICS SA Ordinary Shares.
Does Rallies show 13F holders for SOPH?
Yes. Rallies tracks hedge fund and 13F ownership data for SOPH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SOPH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SOPH. It does not provide personalized investment advice.
